SignatureFD’s Definium Therapeutics DFTX Stock Holding History

SignatureFD’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88K	Buy	+40	New	+$988	﹤0.01%	3143
2026 Q1	–	Sell	-2	Closed	-$27	–	3551
2025 Q4	$27	Hold	2	–	–	﹤0.01%	3354
2025 Q3	$24	Hold	2	–	–	﹤0.01%	3349
2025 Q2	$13	Hold	2	–	–	﹤0.01%	3239
2025 Q1	$12	Hold	2	–	–	﹤0.01%	3301
2024 Q4	$14	Hold	2	–	–	﹤0.01%	3282
2024 Q3	$11	Sell	2 -66	-97%	-$459	﹤0.01%	3220
2024 Q2	$490	Hold	68	–	–	﹤0.01%	2990
2024 Q1	$639	Hold	68	–	–	﹤0.01%	3004
2023 Q4	$249	Hold	68	–	–	﹤0.01%	3040
2023 Q3	$213	Buy	68 +66	+3,300%	+$271	﹤0.01%	3088
2023 Q2	$7	Hold	2	–	–	﹤0.01%	3219
2023 Q1	$6	Hold	2	–	–	﹤0.01%	3267
2022 Q4	$4	Sell	2 -2	-50%	-$6	﹤0.01%	3272
2022 Q3	$0	Buy	4 +2	+100%	+$19	﹤0.01%	3256
2022 Q2	$0	Hold	2	–	–	﹤0.01%	3260
2022 Q1	$0	Hold	2	–	–	﹤0.01%	3257
2021 Q4	$0	Hold	2	–	–	﹤0.01%	3205
2021 Q3	$0	Hold	2	–	–	﹤0.01%	3151
2021 Q2	$0	Buy	+2	New	+$105	﹤0.01%	3012

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

SignatureFD's DFTX Position: Q2 2026 in Review

SignatureFD opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 40 shares worth $1.88K. The stake represents ﹤0.01% of the portfolio and ranks #3143 among its holdings. This is a return to the name: SignatureFD previously reported a position in DFTX as recently as Q4 2025.

SignatureFD first reported a position in DFTX in Q2 2021 and has held it in 20 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

SignatureFD held 40 shares of Definium Therapeutics worth $1.88K as of Q2 2026.
Definium Therapeutics was a new SignatureFD position in Q2 2026.
Definium Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3143 holding.
SignatureFD first reported a position in Definium Therapeutics in Q2 2021 and has held it in 20 quarters since.
361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.